RESUMO
BACKGROUND: An orbital implant is used after enucleation or evisceration surgery to replace the volume lost and to aid in prosthesis fitting and movement. Different materials have been used through the years. The authors noted that with bone-derived hydroxyapatite orbital implants, some patients lose their orbital volume. METHODS: The operating theatre record was searched to find patients who had their hydroxyapatite orbital implant removed at Dunedin Hospital, New Zealand, between 2011 and 2015. The original implant size and size at removal were noted. Histological results were noted. Medical notes were reviewed. RESULTS: A total of six patients had hydroxyapatite orbital implants removed during this time. Four patients had implants that were smaller than their original sizes. All specimens had fibrovascular infiltration noted, three had chronic inflammatory cells and one had osteoclastic activity. CONCLUSIONS: Bone-derived hydroxyapatite orbital implants can reduce in size, and this may occur due to osteoclastic activity. The surgeon must consider this scenario when choosing the type of implant to be used after enucleation or evisceration.
Assuntos
Enucleação Ocular/métodos , Hidroxiapatitas , Implantes Orbitários , Complicações Pós-Operatórias , Idoso , Materiais Biocompatíveis , Olho Artificial , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Nova Zelândia , Complicações Pós-Operatórias/etiologia , Próteses e ImplantesAssuntos
Conservadores da Densidade Óssea/efeitos adversos , Inflamação/induzido quimicamente , Doenças Orbitárias/induzido quimicamente , Ácido Zoledrônico/efeitos adversos , Feminino , Glucocorticoides/uso terapêutico , Humanos , Inflamação/diagnóstico por imagem , Inflamação/tratamento farmacológico , Metilprednisolona/uso terapêutico , Pessoa de Meia-Idade , Doenças Orbitárias/diagnóstico por imagem , Doenças Orbitárias/tratamento farmacológico , Osteoporose Pós-Menopausa/tratamento farmacológico , Tomografia Computadorizada por Raios XRESUMO
In systemic lupus erythematosus, ophthalmic manifestations are noted in up to one-third of patients. We describe a patient with an unusual initial presentation of this disorder.
Assuntos
Dacriocistite/diagnóstico , Pálpebras/patologia , Lúpus Eritematoso Sistêmico/diagnóstico , Adulto , Pálpebras/diagnóstico por imagem , Feminino , Humanos , Tomografia Computadorizada por Raios XRESUMO
We report a case of tympanic membrane rupture during snorkeling in a 17-year-old young man who had previously undergone bilateral Jones tubes placed for epiphora. To our knowledge, this phenomenon has not been previously reported.
Assuntos
Dacriocistorinostomia/instrumentação , Mergulho/efeitos adversos , Intubação/instrumentação , Doenças do Aparelho Lacrimal/cirurgia , Adolescente , Humanos , Doenças do Aparelho Lacrimal/diagnóstico , Doenças do Aparelho Lacrimal/etiologia , MasculinoAssuntos
Blefaroptose/diagnóstico , Doenças da Túnica Conjuntiva/diagnóstico , Granuloma Eosinófilo/diagnóstico , Doenças Orbitárias/diagnóstico , Blefaroptose/tratamento farmacológico , Doenças da Túnica Conjuntiva/tratamento farmacológico , Dexametasona/uso terapêutico , Granuloma Eosinófilo/tratamento farmacológico , Feminino , Glucocorticoides/uso terapêutico , Humanos , Pessoa de Meia-Idade , Doenças Orbitárias/tratamento farmacológico , RecidivaRESUMO
A case of bilateral upper eyelid ptosis in an HIV-infected patient with severe antiretroviral-associated facial lipodystrophy is presented. The features, treatment, and outcome are discussed. Dehiscence of the levator aponeurosis may be directly associated with highly active antiretroviral therapy-induced lipodystrophy.
Assuntos
Blefaroplastia/métodos , Blefaroptose/etiologia , Síndrome de Lipodistrofia Associada ao HIV/complicações , Músculos Oculomotores/patologia , Fármacos Anti-HIV/uso terapêutico , Terapia Antirretroviral de Alta Atividade , Blefaroptose/cirurgia , Didanosina/uso terapêutico , Quimioterapia Combinada , Síndrome de Lipodistrofia Associada ao HIV/tratamento farmacológico , Humanos , Masculino , Pessoa de Meia-Idade , Nelfinavir/uso terapêutico , Músculos Oculomotores/cirurgia , Estavudina/uso terapêuticoRESUMO
The association of an absent upper eyelid skin crease on downgaze with hypoglobus has not been described in the literature before. Herein a case of silent sinus syndrome that demonstrates this sign is described. The possible mechanism of such a sign is discussed.
Assuntos
Enoftalmia/diagnóstico , Doenças Palpebrais/diagnóstico , Seio Maxilar/patologia , Doenças dos Seios Paranasais/diagnóstico , Dermatopatias/diagnóstico , Adulto , Feminino , Humanos , Imageamento por Ressonância Magnética , Tomografia Computadorizada por Raios XAssuntos
Blefaroptose/etiologia , Conjuntivite Alérgica/complicações , Granuloma Eosinófilo/complicações , Granuloma de Células Gigantes/complicações , Conjuntivite Alérgica/diagnóstico , Conjuntivite Alérgica/tratamento farmacológico , Granuloma Eosinófilo/diagnóstico , Granuloma Eosinófilo/tratamento farmacológico , Feminino , Glucocorticoides/uso terapêutico , Granuloma de Células Gigantes/diagnóstico , Granuloma de Células Gigantes/tratamento farmacológico , Humanos , Pessoa de Meia-IdadeRESUMO
PURPOSE. To report an unidentified species of atypical Mycobacterium as the causative agent of a primary orbital roof infection. METHOD. Review of a case from the King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia. RESULTS. The patient had a negative history for eye trauma. Computed tomography (CT) of the brain and right orbit confirmed the presence of soft tissue swelling and erosive changes in the orbital roof bone, with intact globe and external ocular muscles. Biopsy of the lesion showed non-caseating, granulomatous osteomyelitis. Various stains of the sample were negative. Since our institution could not identify the causative organism, a biopsy sample was sent to Bioscientia Laboratory in Germany; the culture grew an atypical Mycobacterium of unknown species. Their sensitivity study showed the organism to be resistant to pyrazinamide, isoniazide and streptomycin, but sensitive to rifampicin, ethambutol, and prothionamide. Systemic checkup and investigation ruled out any other systemic involvement. CONCLUSION. A new species of atypical Mycobacterium was recovered from a primary orbital infection. The infection responded to combined antituberculous therapy.